Literature DB >> 34317723

Commentary: Scimitar syndrome: Cutting through the details.

Jeremy L Herrmann1,2, John W Brown1,2.   

Abstract

Entities:  

Year:  2020        PMID: 34317723      PMCID: PMC8288718          DOI: 10.1016/j.xjtc.2019.12.009

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
Methods of scimitar vein repair with intracardiac baffle and/or reimplantation. This state-of-the-art, comprehensive review offers detailed insights into the pathophysiology, diagnosis, and surgical management of scimitar syndrome. See Article page 75. Vida and Guariento provide a timely, comprehensive review of pathophysiology, principles of diagnostic evaluation, and considerations for surgical repair for patients with scimitar syndrome. This contribution complements their recent retrospective, multicenter from Europe including 485 patients who were treated medically or surgically across 51 centers. Using this largest study of its kind, the authors provide a true state-of-the-art assessment of this highly variable clinical entity. The first surgical correction of scimitar syndrome (although not yet known as this) was reported by Kirklin and colleagues in 1956 for a 32-year-old female patient. They used a combination of scimitar vein reimplantation and construction of an intracardiac baffle previously described by Bailey and colleagues 3 years previously. It is interesting that these concepts are still the most commonly used techniques for scimitar vein repair. Based on this review, we understand that scimitar syndrome remains an uncommon condition with variable presentation. Overall survival following surgical correction remains very good, although there is a very real incidence of late scimitar vein stenosis/occlusion following repair. Outcomes inversely relate to patient age, as infants tend to be more symptomatic and exhibit a greater rate of reintervention. Fortunately, many stenoses or obstructions can be managed with transcatheter techniques. Clearly, lifelong cardiology follow-up is very important in these patients. What remains to be seen is how these patients continue to fare into later adulthood. Furthermore, do different techniques confer different outcomes, and not just in terms of overall survival? The authors postulate that, given current data, younger patients may benefit more from an intracardiac baffle versus reimplantation. However, the subtle nuances of the various repairs are difficult to glean from this review and the recent European study. Since 1990, we have favored reimplantation repair using a right thoracotomy, off-bypass approach when no significant atrial septal defect is present., In total, we have treated 18 patients (median age 5.8 years, interquartile range 2.2-37 years), and at a median follow-up of 14 months (interquartile range 2.1-54 months), there have been no mortalities or reinterventions. Multicenter studies will continue to be needed to generate adequate statistical power for identifying any procedure-related outcomes and long-term risk factors. Hopefully, such concerted efforts will support the development of management guidelines for the treatment of scimitar syndrome.
  6 in total

1.  Treatment of anomalous pulmonary venous connections in association with interatrial communications.

Authors:  J W KIRKLIN; F H ELLIS; E H WOOD
Journal:  Surgery       Date:  1956-03       Impact factor: 3.982

2.  Atrio-septo-pexy for interatrial septal defects.

Authors:  C P BAILEY; H E BOLTON; W L JAMISON; W B NEPTUNE
Journal:  J Thorac Surg       Date:  1953-08

Review 3.  Scimitar syndrome.

Authors:  Ulf Gudjonsson; John W Brown
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

4.  Surgical management of scimitar syndrome: an alternative approach.

Authors:  John W Brown; Mark Ruzmetov; Douglas J Minnich; Palaniswamy Vijay; Christopher A Edwards; Paul N Uhlig; Andrew C Fiore; Mark W Turrentine
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

5.  The natural history and surgical outcome of patients with scimitar syndrome: a multi-centre European study.

Authors:  Vladimiro L Vida; Alvise Guariento; Ornella Milanesi; Dario Gregori; Giovanni Stellin
Journal:  Eur Heart J       Date:  2018-03-21       Impact factor: 29.983

6.  A sword threatening the heart: The scimitar syndrome.

Authors:  Vladimiro L Vida; Alvise Guariento
Journal:  JTCVS Tech       Date:  2020-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.